#acc26

Anya Rossi

sweetdream.ai

SweetDream.ai•Sponsored•Livecam

Watch Anya Live

Anya is streaming live right now! Join her private show and enjoy exclusive content.

Exclusive private shows

1.2k viewers online

Private Show

Join now for exclusive access

Free preview available • Premium content

#ACC26 is just a few days away! 📆Join me on Sat 3/28 2:30pm CT for How the Cardiology Community Can Combat Medical Misinformation 🤨Is social media still an opportunity to promote evidence-based medicine? #socialmedia #medicine #cardiotwitter

#ACC26 is just a few days away! 📆Join me on Sat 3/28 2:30pm CT for How the Cardiology Community Can Combat Medical Misinformation 🤨Is social media still an opportunity to promote evidence-based medicine? #socialmedia #medicine #cardiotwitter

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

23,107 views • 4 months ago

Among patients with #diabetes but without known significant atherosclerosis, intensive LDL-C lowering with evolocumab plus statin reduced risk of first major cardiovascular event vs placebo in the VESALIUS-CV trial. #ACC26 American College of Cardiology 🎥 Watch the video and read the full article:

Among patients with #diabetes but without known significant atherosclerosis, intensive LDL-C lowering with evolocumab plus statin reduced risk of first major cardiovascular event vs placebo in the VESALIUS-CV trial. #ACC26 American College of Cardiology 🎥 Watch the video and read the full article:

14,124 views • 4 months ago

📹 Watch experts share who they’re most excited to connect w/ at #ACC26! 👇 Get ready for meaningful connections, new ideas, inspiration, & more. Who are you looking forward to meeting? Join the 🌍 cardiovascular community at #ACC26 – 1️⃣ month to go! ➡️

📹 Watch experts share who they’re most excited to connect w/ at #ACC26! 👇 Get ready for meaningful connections, new ideas, inspiration, & more. Who are you looking forward to meeting? Join the 🌍 cardiovascular community at #ACC26 – 1️⃣ month to go! ➡️

American College of Cardiology

12,794 views • 5 months ago

From setup to showtime, everything is coming to life. 🫀 A final walkthrough with #ACC26 Chair Katie Berlacher, MD, MS, FACC, Vice Chair Julie Damp, MD, FACC, and CV Team Lead Kristen Campbell, PharmD, CPP, FACC. 👀 The wait is almost over. Let the #ACC26 experience begin! 🎉

From setup to showtime, everything is coming to life. 🫀 A final walkthrough with #ACC26 Chair Katie Berlacher, MD, MS, FACC, Vice Chair Julie Damp, MD, FACC, and CV Team Lead Kristen Campbell, PharmD, CPP, FACC. 👀 The wait is almost over. Let the #ACC26 experience begin! 🎉

American College of Cardiology

10,957 views • 4 months ago

Dr. Saibal Kar and Dr. C. Michael Gibson discuss the CHAMPION-AF trial: Left atrial appendage closure with the WATCHMAN FLX device was non-inferior to DOACs for the composite of CV death, stroke, or systemic embolism among patients with non-valvular AFib. #ACC26 Watch video here:

Dr. Saibal Kar and Dr. C. Michael Gibson discuss the CHAMPION-AF trial: Left atrial appendage closure with the WATCHMAN FLX device was non-inferior to DOACs for the composite of CV death, stroke, or systemic embolism among patients with non-valvular AFib. #ACC26 Watch video here:

C. Michael Gibson MD

10,732 views • 4 months ago

Drs. Fred M. Kusumoto and Beth Dineen (Hill), DO, FACC share what they’re most excited about at #ACC26, from pre-conference sessions to late-breaking clinical trials. 📹 Watch the video 👇 and learn more about everything ACC.26 has to offer ➡️ #ACCAnywhere #CardioX

Drs. Fred M. Kusumoto and Beth Dineen (Hill), DO, FACC share what they’re most excited about at #ACC26, from pre-conference sessions to late-breaking clinical trials. 📹 Watch the video 👇 and learn more about everything ACC.26 has to offer ➡️ #ACCAnywhere #CardioX

American College of Cardiology

12,737 views • 5 months ago

Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the MOMENTUM study: Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism, a significantly higher prevalence than previously recognized. #ACC26 Watch video here:

Dr. Deepak Bhatt and Dr. C. Michael Gibson discuss the MOMENTUM study: Among U.S. patients with resistant HTN, 27.3% were found to have endogenous hypercortisolism, a significantly higher prevalence than previously recognized. #ACC26 Watch video here:

C. Michael Gibson MD

10,094 views • 4 months ago

From meaningful connections to memorable moments, #ACC26 is where collaboration comes to life. 🪄 🤝 Network with peers 🫀 Engage with experts ❓ Ask your questions ✨ …and more! Join the excitement, make connections, and be part of the action ➡️

From meaningful connections to memorable moments, #ACC26 is where collaboration comes to life. 🪄 🤝 Network with peers 🫀 Engage with experts ❓ Ask your questions ✨ …and more! Join the excitement, make connections, and be part of the action ➡️

American College of Cardiology

11,393 views • 6 months ago

No more content to load